Literature DB >> 22005943

Use of annual mammography among older women with ductal carcinoma in situ.

Phyllis Brawarsky1, Bridget A Neville, Garrett M Fitzmaurice, Michael J Hassett, Jennifer S Haas.   

Abstract

BACKGROUND: As ductal carcinoma in situ (DCIS) is a risk factor for invasive breast cancer, ongoing annual mammography is important for cancer control, yet little is known about racial/ethnic and other disparities in use among older women with DCIS.
METHODS: SEER-Medicare data was used to identify women age 65-85 years, diagnosed with DCIS from 1992 to 2005 and treated with surgery, but not bilateral mastectomy. We examined factors associated with receipt of an initial mammogram within 1 year of treatment and subsequent annual mammograms for 3 and 5 years. We examined whether follow-up care, by a primary care physician or cancer specialist, or neighborhood characteristics mediated disparities in mammography use.
RESULTS: Overall, 91.3% of women had an initial mammogram. After adjustment, blacks and Hispanics were less likely than whites to receive an initial mammogram (odds ratio (OR) 0.74, 95% confidence interval (CI) 0.55-0.99 and OR 0.65, CI 0.46-0.93, respectively, as were women of lower socioeconomic status (SES), women who had a mastectomy or breast conserving surgery without radiation therapy, and women who did not have a physician visit. Overall rates of annual mammography decreased over time. Disparities by SES, initial treatment type, and physician visit did not diminish over time. Physician visits had a modest effect on reducing initial racial/ethnic disparities.
CONCLUSIONS: Annual mammography among women age 65 to 85 with DCIS declines as women get further from diagnosis. Interventions should focus on reducing disparities in the use of initial surveillance mammography, and increasing surveillance over time.

Entities:  

Mesh:

Year:  2011        PMID: 22005943      PMCID: PMC3326107          DOI: 10.1007/s11606-011-1918-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  35 in total

1.  5-Year mammography rates and associated factors for older women.

Authors:  R Van Harrison; Nancy K Janz; Robert A Wolfe; Philip J Tedeschi; Xuelin Huang; Laurence F McMahon
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

2.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

3.  American Cancer Society guidelines for breast cancer screening: update 2003.

Authors:  Robert A Smith; Debbie Saslow; Kimberly Andrews Sawyer; Wylie Burke; Mary E Costanza; W Phil Evans; Roger S Foster; Edward Hendrick; Harmon J Eyre; Steven Sener
Journal:  CA Cancer J Clin       Date:  2003 May-Jun       Impact factor: 508.702

Review 4.  Disparities in screening mammography. Current status, interventions and implications.

Authors:  Monica E Peek; Jini H Han
Journal:  J Gen Intern Med       Date:  2004-02       Impact factor: 5.128

5.  Breast cancer screening and socioeconomic status--35 metropolitan areas, 2000 and 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-10-07       Impact factor: 17.586

6.  The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.

Authors:  Joan L Warren; Donald L Weaver; Therese Bocklage; Charles R Key; Charles E Platz; Kathleen A Cronin; Rachel Ballard-Barbash; Shawna C Willey; Linda C Harlan
Journal:  Cancer       Date:  2005-11-01       Impact factor: 6.860

7.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

8.  Underutilization of mammography in older breast cancer survivors.

Authors:  M M Schapira; T L McAuliffe; A B Nattinger
Journal:  Med Care       Date:  2000-03       Impact factor: 2.983

9.  Risk of contralateral breast cancer among women with carcinoma in situ of the breast.

Authors:  L A Habel; R E Moe; J R Daling; S Holte; M A Rossing; N S Weiss
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

Review 10.  The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.

Authors:  Elizabeth B Claus; Meredith Stowe; Darryl Carter; Theodore Holford
Journal:  Breast       Date:  2003-12       Impact factor: 4.380

View more
  5 in total

1.  Use of Surveillance Mammography Among Older Breast Cancer Survivors by Life Expectancy.

Authors:  Rachel A Freedman; Nancy L Keating; Lydia E Pace; Joyce Lii; Ellen P McCarthy; Mara A Schonberg
Journal:  J Clin Oncol       Date:  2017-07-27       Impact factor: 44.544

2.  Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S.

Authors:  Rebecca A Hubbard; Ellen S O'Meara; Louise M Henderson; Deirdre Hill; Dejana Braithwaite; Jennifer S Haas; Christoph I Lee; Brian L Sprague; Jennifer Alford-Teaster; Anna N A Tosteson; Karen J Wernli; Tracy Onega
Journal:  Prev Med       Date:  2016-05-31       Impact factor: 4.018

Review 3.  Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.

Authors:  Rachel A Freedman; Nancy L Keating; Ann H Partridge; Hyman B Muss; Arti Hurria; Eric P Winer
Journal:  JAMA Oncol       Date:  2017-03-01       Impact factor: 31.777

Review 4.  Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review.

Authors:  Pragati Advani; Shailesh Advani; Pratibha Nayak; Helena M VonVille; Pamela Diamond; Jason Burnett; Abenaa M Brewster; Sally W Vernon
Journal:  J Cancer Surviv       Date:  2021-05-13       Impact factor: 4.442

Review 5.  Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement.

Authors:  Rachel A Freedman; Christina A Minami; Eric P Winer; Monica Morrow; Alexander K Smith; Louise C Walter; Mina S Sedrak; Haley Gagnon; Adriana Perilla-Glen; Hans Wildiers; Tanya M Wildes; Stuart M Lichtman; Kah Poh Loh; Etienne G C Brain; Pamela S Ganschow; Kelly K Hunt; Deborah K Mayer; Kathryn J Ruddy; Reshma Jagsi; Nancy U Lin; Beverly Canin; Barbara K LeStage; Anna C Revette; Mara A Schonberg; Nancy L Keating
Journal:  JAMA Oncol       Date:  2021-04-01       Impact factor: 33.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.